MORGAN STANLEY DIRECT LENDIN (MSDL)

US61774A1034 - Common Stock

20.82  -0.09 (-0.43%)

After market: 20.75 -0.07 (-0.34%)

Fundamental Rating

4

MSDL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 219 industry peers in the Capital Markets industry. While MSDL is still in line with the averages on profitability rating, there are concerns on its financial health. MSDL has a valuation in line with the averages, but it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

In the past year MSDL was profitable.
In the past year MSDL has reported a negative cash flow from operations.

1.2 Ratios

MSDL's Return On Assets of 5.83% is fine compared to the rest of the industry. MSDL outperforms 75.70% of its industry peers.
MSDL has a better Return On Equity (11.94%) than 67.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.87%, MSDL is in the better half of the industry, outperforming 62.15% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MSDL is below the industry average of 6.63%.
The last Return On Invested Capital (4.87%) for MSDL is above the 3 year average (3.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.83%
ROE 11.94%
ROIC 4.87%
ROA(3y)3.98%
ROA(5y)N/A
ROE(3y)7.97%
ROE(5y)N/A
ROIC(3y)3.58%
ROIC(5y)N/A

1.3 Margins

MSDL has a Profit Margin of 53.49%. This is amongst the best in the industry. MSDL outperforms 91.12% of its industry peers.
Looking at the Operating Margin, with a value of 55.08%, MSDL belongs to the top of the industry, outperforming 90.65% of the companies in the same industry.
MSDL's Gross Margin of 52.36% is in line compared to the rest of the industry. MSDL outperforms 54.67% of its industry peers.
Industry RankSector Rank
OM 55.08%
PM (TTM) 53.49%
GM 52.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, MSDL has about the same amount of shares outstanding.
The debt/assets ratio for MSDL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that MSDL is in the distress zone and has some risk of bankruptcy.
MSDL has a Altman-Z score (0.90) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.99 indicates that MSDL is somewhat dependend on debt financing.
MSDL has a Debt to Equity ratio (0.99) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MSDL has a Current Ratio of 1.38. This is a normal value and indicates that MSDL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.38, MSDL is in line with its industry, outperforming 59.35% of the companies in the same industry.
MSDL has a Quick Ratio of 1.38. This is a normal value and indicates that MSDL is financially healthy and should not expect problems in meeting its short term obligations.
MSDL's Quick ratio of 1.38 is in line compared to the rest of the industry. MSDL outperforms 59.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 375.91% over the past year.
MSDL shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.47%.
EPS 1Y (TTM)375.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.32%
Revenue 1Y (TTM)59.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.2%

3.2 Future

The Earnings Per Share is expected to decrease by -7.71% on average over the next years.
MSDL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.18% yearly.
EPS Next Y-4.88%
EPS Next 2Y-8.19%
EPS Next 3Y-7.71%
EPS Next 5YN/A
Revenue Next Year8.41%
Revenue Next 2Y3.41%
Revenue Next 3Y0.18%
Revenue Next 5YN/A

3.3 Evolution

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.04 indicates a reasonable valuation of MSDL.
Compared to the rest of the industry, the Price/Earnings ratio of MSDL indicates a rather cheap valuation: MSDL is cheaper than 80.37% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MSDL to the average of the S&P500 Index (27.41), we can say MSDL is valued rather cheaply.
The Price/Forward Earnings ratio is 9.10, which indicates a very decent valuation of MSDL.
74.77% of the companies in the same industry are more expensive than MSDL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.69. MSDL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.04
Fwd PE 9.1

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as MSDL's earnings are expected to decrease with -7.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.19%
EPS Next 3Y-7.71%

4

5. Dividend

5.1 Amount

MSDL has a Yearly Dividend Yield of 12.97%, which is a nice return.
Compared to an average industry Dividend Yield of 9.65, MSDL pays a better dividend. On top of this MSDL pays more dividend than 81.31% of the companies listed in the same industry.
MSDL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 12.97%

5.2 History

MSDL is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y-8.19%
EPS Next 3Y-7.71%

MORGAN STANLEY DIRECT LENDIN

NYSE:MSDL (1/3/2025, 8:04:01 PM)

After market: 20.75 -0.07 (-0.34%)

20.82

-0.09 (-0.43%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners15.8%
Inst Owner Change283.02%
Ins Owners0.2%
Ins Owner Change0%
Market Cap1.85B
Analysts73.33
Price Target21.73 (4.37%)
Short Float %0.15%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 12.97%
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.04%
Min EPS beat(2)-0.7%
Max EPS beat(2)0.79%
EPS beat(4)1
Avg EPS beat(4)-1.27%
Min EPS beat(4)-4.39%
Max EPS beat(4)0.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.58%
Min Revenue beat(2)0.23%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.05%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.31%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.35%
PT rev (3m)-0.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.32%
EPS NY rev (1m)0%
EPS NY rev (3m)0.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)4.04%
Revenue NY rev (3m)-5.14%
Valuation
Industry RankSector Rank
PE 8.04
Fwd PE 9.1
P/S 4.47
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)2.59
EY12.44%
EPS(NY)2.29
Fwd EY10.99%
FCF(TTM)-2.87
FCFYN/A
OCF(TTM)-2.87
OCFYN/A
SpS4.66
BVpS20.88
TBVpS20.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.83%
ROE 11.94%
ROCE 6.17%
ROIC 4.87%
ROICexc 4.99%
ROICexgc 4.99%
OM 55.08%
PM (TTM) 53.49%
GM 52.36%
FCFM N/A
ROA(3y)3.98%
ROA(5y)N/A
ROE(3y)7.97%
ROE(5y)N/A
ROIC(3y)3.58%
ROIC(5y)N/A
ROICexc(3y)3.67%
ROICexc(5y)N/A
ROICexgc(3y)3.67%
ROICexgc(5y)N/A
ROCE(3y)4.53%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.19
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z 0.9
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)375.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.32%
EPS Next Y-4.88%
EPS Next 2Y-8.19%
EPS Next 3Y-7.71%
EPS Next 5YN/A
Revenue 1Y (TTM)59.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.2%
Revenue Next Year8.41%
Revenue Next 2Y3.41%
Revenue Next 3Y0.18%
Revenue Next 5YN/A
EBIT growth 1Y55.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.5%
OCF growth 3YN/A
OCF growth 5YN/A